vs

Side-by-side financial comparison of COFFEE HOLDING CO INC (JVA) and KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS). Click either name above to swap in a different company.

COFFEE HOLDING CO INC is the larger business by last-quarter revenue ($27.7M vs $22.6M, roughly 1.2× KESTRA MEDICAL TECHNOLOGIES, LTD.). COFFEE HOLDING CO INC runs the higher net margin — 2.9% vs -145.3%, a 148.2% gap on every dollar of revenue. COFFEE HOLDING CO INC produced more free cash flow last quarter ($265.4K vs $-25.6M).

Black Rifle Coffee Company (BRCC) is a coffee company based in Salt Lake City, Utah, United States. Founded in 2014 by former U.S. Army Green Beret Evan Hafer, it gained national attention in 2017 after pledging to hire 10,000 veterans in response to Starbucks's pledge to hire 10,000 refugees.

Kestra Medical Technologies, Ltd. is a medical device firm that develops, manufactures and commercializes innovative minimally invasive therapeutic solutions, mainly for interventional cardiology and structural heart disease treatment. It operates across North America, Europe and key Asia-Pacific markets, serving global healthcare providers and patients.

JVA vs KMTS — Head-to-Head

Bigger by revenue
JVA
JVA
1.2× larger
JVA
$27.7M
$22.6M
KMTS
Higher net margin
JVA
JVA
148.2% more per $
JVA
2.9%
-145.3%
KMTS
More free cash flow
JVA
JVA
$25.9M more FCF
JVA
$265.4K
$-25.6M
KMTS

Income Statement — Q4 FY2025 vs Q2 FY2026

Metric
JVA
JVA
KMTS
KMTS
Revenue
$27.7M
$22.6M
Net Profit
$811.5K
$-32.8M
Gross Margin
8.5%
50.6%
Operating Margin
2.8%
-140.7%
Net Margin
2.9%
-145.3%
Revenue YoY
30.8%
Net Profit YoY
-35.7%
EPS (diluted)
$0.15
$-0.64

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
JVA
JVA
KMTS
KMTS
Q4 25
$27.7M
$22.6M
Q3 25
$23.9M
$19.4M
Q2 25
$23.3M
Q1 25
$21.3M
Q4 24
$21.2M
Q3 24
$18.8M
Q2 24
$19.0M
Q1 24
$19.5M
Net Profit
JVA
JVA
KMTS
KMTS
Q4 25
$811.5K
$-32.8M
Q3 25
$-1.2M
$-25.8M
Q2 25
$644.1K
Q1 25
$1.2M
Q4 24
$1.3M
Q3 24
$626.8K
Q2 24
$-21.8K
Q1 24
$351.0K
Gross Margin
JVA
JVA
KMTS
KMTS
Q4 25
8.5%
50.6%
Q3 25
12.2%
45.7%
Q2 25
18.9%
Q1 25
26.9%
Q4 24
23.2%
Q3 24
20.9%
Q2 24
19.5%
Q1 24
17.8%
Operating Margin
JVA
JVA
KMTS
KMTS
Q4 25
2.8%
-140.7%
Q3 25
-4.6%
-149.1%
Q2 25
3.8%
Q1 25
7.5%
Q4 24
8.0%
Q3 24
3.8%
Q2 24
-0.4%
Q1 24
3.2%
Net Margin
JVA
JVA
KMTS
KMTS
Q4 25
2.9%
-145.3%
Q3 25
-5.0%
-133.3%
Q2 25
2.8%
Q1 25
5.4%
Q4 24
5.9%
Q3 24
3.3%
Q2 24
-0.1%
Q1 24
1.8%
EPS (diluted)
JVA
JVA
KMTS
KMTS
Q4 25
$0.15
$-0.64
Q3 25
$-0.21
$-0.50
Q2 25
$0.11
Q1 25
$0.20
Q4 24
$0.22
Q3 24
$0.11
Q2 24
$0.00
Q1 24
$0.06

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
JVA
JVA
KMTS
KMTS
Cash + ST InvestmentsLiquidity on hand
$701.9K
$175.4M
Total DebtLower is stronger
Stockholders' EquityBook value
$27.6M
$164.1M
Total Assets
$42.0M
$246.7M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
JVA
JVA
KMTS
KMTS
Q4 25
$701.9K
$175.4M
Q3 25
$979.8K
$201.2M
Q2 25
$1.8M
Q1 25
$2.4M
Q4 24
$1.4M
Q3 24
$3.1M
Q2 24
$2.4M
Q1 24
$2.4M
Stockholders' Equity
JVA
JVA
KMTS
KMTS
Q4 25
$27.6M
$164.1M
Q3 25
$26.8M
$184.2M
Q2 25
$28.0M
Q1 25
$27.3M
Q4 24
$26.2M
Q3 24
$24.9M
Q2 24
$24.3M
Q1 24
$24.3M
Total Assets
JVA
JVA
KMTS
KMTS
Q4 25
$42.0M
$246.7M
Q3 25
$45.9M
$266.3M
Q2 25
$39.7M
Q1 25
$38.9M
Q4 24
$34.0M
Q3 24
$33.1M
Q2 24
$34.9M
Q1 24
$37.6M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
JVA
JVA
KMTS
KMTS
Operating Cash FlowLast quarter
$377.7K
$-18.3M
Free Cash FlowOCF − Capex
$265.4K
$-25.6M
FCF MarginFCF / Revenue
1.0%
-113.5%
Capex IntensityCapex / Revenue
0.4%
32.2%
Cash ConversionOCF / Net Profit
0.47×
TTM Free Cash FlowTrailing 4 quarters
$-5.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
JVA
JVA
KMTS
KMTS
Q4 25
$377.7K
$-18.3M
Q3 25
$-3.8M
$-26.3M
Q2 25
$-1.2M
Q1 25
$-401.9K
Q4 24
$222.0K
Q3 24
$1.8M
Q2 24
$-1.2M
Q1 24
$4.6M
Free Cash Flow
JVA
JVA
KMTS
KMTS
Q4 25
$265.4K
$-25.6M
Q3 25
$-3.9M
$-34.4M
Q2 25
$-1.2M
Q1 25
$-419.8K
Q4 24
Q3 24
$1.8M
Q2 24
Q1 24
FCF Margin
JVA
JVA
KMTS
KMTS
Q4 25
1.0%
-113.5%
Q3 25
-16.3%
-177.8%
Q2 25
-5.0%
Q1 25
-2.0%
Q4 24
Q3 24
9.4%
Q2 24
Q1 24
Capex Intensity
JVA
JVA
KMTS
KMTS
Q4 25
0.4%
32.2%
Q3 25
0.2%
42.2%
Q2 25
0.1%
Q1 25
0.1%
Q4 24
Q3 24
0.2%
Q2 24
Q1 24
Cash Conversion
JVA
JVA
KMTS
KMTS
Q4 25
0.47×
Q3 25
Q2 25
-1.79×
Q1 25
-0.35×
Q4 24
0.18×
Q3 24
2.90×
Q2 24
Q1 24
13.09×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons